tiprankstipranks
Nutra Pharma Corp. (NPHC)
OTHER OTC:NPHC
US Market
NPHC
Nutra Pharma
RESEARCH TOOLSreports

Nutra Pharma (NPHC) Ratios

19 Followers

Nutra Pharma Ratios

NPHC's free cash flow for Q2 2026 was $0.95. For the 2026 fiscal year, NPHC's free cash flow was decreased by $ and operating cash flow was $-12.64. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
 0.02 0.03 0.03 0.03 <0.01
Quick Ratio
 0.02 0.03 0.02 0.02 <0.01
Cash Ratio
 0.00 <0.01 0.00 <0.01 -0.01
Solvency Ratio
 -0.25 -0.11 0.62 -0.60 -0.06
Operating Cash Flow Ratio
 -0.05 -0.07 -0.06 -0.08 -0.08
Short-Term Operating Cash Flow Coverage
 -0.09 -0.12 -0.09 -0.23 -0.19
Net Current Asset Value
$ -21.37M$ -16.95M$ -12.80M$ -21.12M$ -11.74M
Leverage Ratios
Debt-to-Assets Ratio
 19.83 16.69 11.33 10.51 16.70
Debt-to-Equity Ratio
 -0.58 -0.58 -0.69 -0.39 -0.44
Debt-to-Capital Ratio
 -1.39 -1.38 -2.24 -0.65 -0.78
Long-Term Debt-to-Capital Ratio
 >-0.01 >-0.01 -0.02 -0.03 -0.02
Financial Leverage Ratio
 -0.03 -0.03 -0.06 -0.04 -0.03
Debt Service Coverage Ratio
 -0.13 -0.14 -0.21 -1.55 -0.07
Interest Coverage Ratio
 -7.64 -3.32 -2.41 -3.87 -2.75
Debt to Market Cap
 17.25 12.55 4.06 0.56 0.62
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -7.69 -7.16 -4.54 -0.65 -14.17
Profitability Margins
Gross Profit Margin
50.38%51.03%56.82%8.66%28.74%
EBIT Margin
-790.74%-379.53%-435.21%-12891.84%-834.36%
EBITDA Margin
-775.84%-353.20%-430.03%-12826.99%-704.59%
Operating Profit Margin
-790.74%-379.53%-435.21%-1964.61%-1782.27%
Pretax Profit Margin
-2618.79%-531.37%1865.70%-13399.01%-1482.14%
Net Profit Margin
-2618.79%-531.37%1865.70%-13399.01%-1482.14%
Continuous Operations Profit Margin
-2618.79%-531.37%1865.70%-13399.01%-1482.14%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
331.18%140.01%-428.69%682.02%83.16%
Return on Assets (ROA)
-870.25%-350.25%1083.15%-1678.87%-254.88%
Return on Equity (ROE)
30.26%12.17%-66.06%62.73%6.69%
Return on Capital Employed (ROCE)
7.77%8.76%15.97%9.43%8.27%
Return on Invested Capital (ROIC)
18.47%20.70%49.86%15.14%14.33%
Return on Tangible Assets
-870.25%-350.25%1083.15%-1678.87%-254.88%
Earnings Yield
-671.94%-263.20%400.00%-90.53%-9.70%
Efficiency Ratios
Receivables Turnover
 0.56 1.03 20.23 0.30 1.29
Payables Turnover
 0.12 0.22 0.26 0.13 0.06
Inventory Turnover
 4.37 9.66 7.93 2.85 7.02
Fixed Asset Turnover
 9.88 14.93 1.32 0.71 0.33
Asset Turnover
 0.33 0.66 0.58 0.13 0.17
Working Capital Turnover Ratio
 -0.01 0.00 -0.03 >-0.01 >-0.01
Cash Conversion Cycle
 -2.42K -1.26K -1.34K -1.41K -5.58K
Days of Sales Outstanding
 656.89 355.17 18.04 1.22K 281.89
Days of Inventory Outstanding
 83.54 37.79 46.03 127.93 52.02
Days of Payables Outstanding
 3.16K 1.65K 1.40K 2.75K 5.92K
Operating Cycle
 740.43 392.97 64.07 1.34K 333.91
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.02 1.08 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
 -524.80K -44.68 -13.15 -44.68 -148.70
Capital Expenditure Coverage Ratio
 -524.80K -44.68 -13.15 -44.68 -148.70
Operating Cash Flow Coverage Ratio
 -0.08 -0.12 -0.09 -0.21 -0.17
Operating Cash Flow to Sales Ratio
 -5.07 -3.02 -1.74 -17.85 -16.92
Free Cash Flow Yield
-146.60%-152.98%-40.13%-12.33%-11.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.12 -0.33 0.25 -1.10 -10.31
Price-to-Sales (P/S) Ratio
 3.46 2.02 4.66 148.00 152.78
Price-to-Book (P/B) Ratio
 -0.04 -0.05 -0.17 -0.69 -0.69
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.68 -0.65 -2.49 -8.11 -8.97
Price-to-Operating Cash Flow Ratio
 -0.77 -0.67 -2.68 -8.29 -9.03
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.00 >-0.01 >-0.01 0.11
Price-to-Fair Value
 -0.04 -0.05 -0.17 -0.69 -0.69
Enterprise Value Multiple
 -8.14 -7.73 -5.62 -1.80 -35.86
Enterprise Value
 13.06M 10.52M 10.60M 22.57M 13.11M
EV to EBITDA
 -8.14 -7.73 -5.62 -1.80 -35.86
EV to Sales
 63.12 27.32 24.18 230.93 252.63
EV to Free Cash Flow
 -12.45 -8.84 -12.92 -12.65 -14.83
EV to Operating Cash Flow
 -12.45 -9.04 -13.90 -12.94 -14.93
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 <0.01 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 3.31 1.40 -4.29 1.04 1.78
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 8.41 4.17 4.92 19.73 21.22
Stock-Based Compensation to Revenue
 0.19 0.07 0.05 1.57 0.16
Income Quality
 0.19 0.57 -0.09 0.13 1.14
Currency in USD